An Economic Evaluation: Simulation of the Cost-Effectiveness and Cost-Utility of Universal Prevention Strategies Against Osteoporosis-Related Fractures

被引:25
|
作者
Nshimyumukiza, Leon [1 ]
Durand, Audrey [1 ,2 ]
Gagnon, Mathieu [1 ]
Douville, Xavier [1 ]
Morin, Suzanne [3 ]
Lindsay, Carmen [4 ]
Duplantie, Julie [1 ]
Gagne, Christian [2 ]
Jean, Sonia [5 ]
Giguere, Yves [4 ,6 ]
Dodin, Sylvie [4 ,7 ]
Rousseau, Francois [4 ,7 ]
Reinharz, Daniel [1 ,4 ]
机构
[1] Univ Laval, Dept Med Sociale & Prevent, Fac Med, Quebec City, PQ G1V 0A6, Canada
[2] Univ Laval, Fac Sci & Genie, Dept Genie Elect, Quebec City, PQ G1V 0A6, Canada
[3] McGill Univ, Fac Med, Dept Internal Med, Montreal, PQ, Canada
[4] Univ Laval, CRCHUQ, Fac Med, Quebec City, PQ G1V 0A6, Canada
[5] Inst Sante Publ Quebec INSPQ, Quebec City, PQ, Canada
[6] Univ Laval, Dept Biol Mol Biochim Med & Pathol, Fac Med, Quebec City, PQ G1V 0A6, Canada
[7] Univ Laval, Dept Obstet & Gynecol, Quebec City, PQ G1V 0A6, Canada
关键词
OSTEOPOROSIS; SCREENING; COMPUTER SIMULATIONS; COST-EFFECTIVENESS; COST-UTILITY; PREVENTION; BONE FRACTURES; BONE-MINERAL DENSITY; CLINICAL-PRACTICE GUIDELINES; QUALITY-OF-LIFE; WOMEN; DIAGNOSIS; CARE; PREFERENCES; VALIDATION; MANAGEMENT; IMPACT;
D O I
10.1002/jbmr.1758
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient-level Markov decision model was used to simulate a virtual cohort of 500,000 women 40 years old and over, in relation to osteoporosis-related hip, clinical vertebral, and wrist bone fractures events. Sixteen different screening options of three main scenario groups were compared: (1) the status quo (no specific national prevention program); (2) a universal primary prevention program; and (3) a universal screening and treatment program based on the 10-year absolute risk of fracture. The outcomes measured were total directs costs from the perspective of the public health care system, number of fractures, and quality-adjusted life-years (QALYs). Results show that an option consisting of a program promoting physical activity and treatment if a fracture occurs is the most cost-effective (CE) (cost/fracture averted) alternative and also the only cost saving one, especially for women 40 to 64 years old. In women who are 65 years and over, bone mineral density (BMD)-based screening and treatment based on the 10-year absolute fracture risk calculated using a Canadian Association of Radiologists and Osteoporosis Canada (CAROC) tool is the best next alternative. In terms of cost-utility (CU), results were similar. For women less than 65 years old, a program promoting physical activity emerged as cost-saving but BMD-based screening with pharmacological treatment also emerged as an interesting alternative. In conclusion, a program promoting physical activity is the most CE and CU option for women 40 to 64 years old. BMD screening and pharmacological treatment might be considered a reasonable alternative for women 65 years old and over because at a healthcare capacity of $50,000 Canadian dollars ($CAD) for each additional fracture averted or for one QALY gained its probabilities of cost-effectiveness compared to the program promoting physical activity are 63% and 75%, respectively, which could be considered socially acceptable. Consideration of the indirect costs could change these findings. (C) 2013 American Society for Bone and Mineral Research.
引用
收藏
页码:383 / 394
页数:12
相关论文
共 50 条
  • [1] COST OF FRACTURES: THE BURDEN AND COST OF OSTEOPOROSIS-RELATED FRACTURES
    Kanis, J. A.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 395 - 396
  • [2] Cost-effectiveness modeling research of pharmacologic therapy to prevent osteoporosis-related fractures
    Schousboe J.T.
    Current Rheumatology Reports, 2007, 9 (1) : 50 - 56
  • [3] An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utility
    Engelgeer, Anouk
    van Westrhenen, Anouk
    Thijs, Roland D.
    Evers, Silvia M. A. A.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2022, 101 : 156 - 161
  • [4] Cost-benefit, cost-effectiveness and cost-utility analyses of periodontitis prevention
    Braegger, U
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2005, 32 : 301 - 313
  • [5] Cost-effectiveness and cost-utility evaluations in radiology
    d'Othée, BJ
    Bettmann, MA
    Pirard, S
    Zhuang, Z
    Black, WC
    JOURNAL DE RADIOLOGIE, 2001, 82 (12): : 1687 - 1692
  • [6] Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis -: Cost-utility analysis using a Markov model
    Kreck, Simon
    Klaus, Jochen
    Leidl, Reiner
    von Tirpitz, Christian
    Konnopka, Alexander
    Matschinger, Herbert
    Koenig, Hans-Helmut
    PHARMACOECONOMICS, 2008, 26 (04) : 311 - 328
  • [8] Cost-effectiveness and cost-utility of long-term management strategies for heartburn
    Goeree, R
    O'Brien, BJ
    Blackhouse, G
    Marshall, J
    Briggs, A
    Lad, R
    VALUE IN HEALTH, 2002, 5 (04) : 312 - 328
  • [9] Economic evaluation of dose–response resistance training in older women: a cost-effectiveness and cost-utility analysis
    J. C. Davis
    C. A. Marra
    M. C. Robertson
    K. M. Khan
    M. Najafzadeh
    M. C. Ashe
    T. Liu-Ambrose
    Osteoporosis International, 2011, 22 : 1355 - 1366
  • [10] A cost-effectiveness and cost-utility study of lung transplantation
    Vasiliadis, HM
    Collet, JP
    Penrod, JR
    Ferraro, P
    Poirier, C
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (09): : 1275 - 1283